NCT05205512Completed
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors (TECHS): A Pilot Feasibility Study
Source: ClinicalTrials.gov · Last updated 6 Oct 2025
Brief summary (registry, in English)
This clinical trial tests how well a telehealth exercise intervention works to improve cardiovascular health in lymphoma survivors. Telehealth exercise is a service to help perform physical exercises at home with a care provider online. With the use of telehealth exercise lymphoma survivors may be able to participate in exercise programs safely to improve heart health and reduce the risk of cardiovascular disease.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 27 Dec 2021
- Start date
- 14 Sept 2022
- Primary completion date
- 9 Jun 2025
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Hodgkin lymphoma
- NCT number
- NCT05205512
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 14 Sept 2022 to the primary completion date, 9 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have overt cardiovascular disease within 6 months (e.g. myocardial infarction, stroke, angina).
Other
- Have contraindications to exercise.
- Participate in structured exercise (\>60 minutes/week).
- Female patients who are pregnant or planning to become pregnant.
Who the study is looking for
- Diagnosed with Hodgkin or non-Hodgkin lymphoma.
- \>= 18 years old.
- Are between 2-5 years after completing anti-cancer therapy and with no evidence of disease.
- Intermediate (4-5) to high ( \>= 6) risk of cardiovascular risk factors based on six key variables: Age 30 to 50 years (y) \[2\]) and \>= 50y \[3\]; anthracycline dose \>250mg/m \^ 2 \[1\]; hypertension \[2\]; diabetes \[2\]; smoking \[1\]; and chest radiation \[1\]).
- Able to understand and sign the informed consent document.
- Physically able and willing to complete all study procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.